Publication | Closed Access

Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer

Early Lung CancerMolecular DeterminantPhotodynamic TherapyMedicinePathologyBronchial NeoplasmBreast CancerCancer TreatmentOncologyRadiation OncologyLung CancerTumor BiologyHealth Sciences